Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-05, Stock:ABBV, The news for the past five days is as follows:
2021-04-28: NEWS1: Is AbbVie a Buy Before Its Earnings Report Friday?.NEWS2: Healthcare ETFs on Radar As Q1 Earnings Unfold.NEWS3: This is Why AbbVie (ABBV) is a Great Dividend Stock.NEWS4: Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings.
2021-04-29: NEWS1: AstraZeneca, Merck, AbbVie Struck Biggest Licensing Deals in 2020.NEWS2: Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales.NEWS3: 2 Undervalued Pharmaceutical Stocks to Buy Now.
2021-04-30: NEWS1: AbbVie Rises on Q1 Beats, Raised EPS Guidance.NEWS2: AbbVie Stock Nears Breakout After First-Quarter Beat And Raise.NEWS3: AbbVie (ABBV) Q1 2021 Earnings Call Transcript.NEWS4: 7 Value Stocks You Want In Your Life.NEWS5: AbbVie (ABBV) Beats on Q1 Earnings, Raises 2021 Guidance.NEWS6: AbbVie Stock Dips Away From Breakout Despite First-Quarter Beat And Raise.NEWS7: How AbbVie Beat Expectations Again in Q1.NEWS8: AbbVie Beats Q1 Earnings On Strong Humira Sales, Raises Full-Year Profit Forecast.NEWS9: UPDATE 2-AbbVie expects Botox sales recovery in Europe after U.S. rebound.NEWS10: AbbVie (ABBV) Surpasses Q1 Earnings and Revenue Estimates.NEWS11: AbbVie's stock is up 2.0% as Humira sales top $4.8 billion in sales in the first quarter.NEWS12: AbbVie Stock Pops On Earnings Beat; Raises 2021 Profit Outlook.NEWS13: Here's Why Shareholders May Want To Be Cautious With Increasing AbbVie Inc.'s (NYSE:ABBV) CEO Pay Packet.NEWS14: 3 Warren Buffett Stocks Worth Buying Now.NEWS15: AbbVie expects Botox sales recovery in Europe after U.S. rebound.NEWS16: AbbVie Reports First-Quarter 2021 Financial Results.NEWS17: AbbVie Posts First-Quarter Earnings Beat and Raises Guidance.
2021-05-03: NEWS1: AbbVie's Humira Still Number 1 in Drug Sales.NEWS2: 3 High-Yield Stocks for Dividend Investors.NEWS3: This Is Why Humira Isn't AbbVie's Biggest Problem Right Now.NEWS4: Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point?.
2021-05-04: NEWS1: AbbVie (ABBV) Stock Moves -0.61%: What You Should Know.NEWS2: Jim Cramer: Don't Bet Against Comebacks in This Second Chance Market.NEWS3: AbbVie Raises EPS Guidance After 1Q Earnings Beat.

Answer: Rise